OpenLegislation

Division II.6.4.3.1.4

United Kingdom

Original text. Later amendments are not shown.

As described in the VICH GL36, the following two endpoints of concern shall be addressed in relation to the establishment of a microbiological ADI:

  1. (a)

    disruption of the colonisation barrier — the first endpoint of concern shall address the question of whether ingestion of residues of antimicrobiologically active substances in food of animal origin poses a risk to human health resulting from the disruption of the colonisation barrier function of the normal intestinal flora;

  2. (b)

    increase of the population of resistant bacteria — the second endpoint of concern shall address the question of whether ingestion of residues of antimicrobiologically active substances pose a risk to human health resulting from an increase in the population of resistant bacteria either due to acquisition of resistance by previously sensitive bacteria or to a relative increase in the proportion of less sensitive organisms.